TREATMENT STRATEGIES, HEALTH CARE RESOURCE USE AND COSTS OF AGGRESSIVE HISTOLOGICAL TYPES OF NON-HODGKIN LYMPHOMAS IN THE SLOVAK REPUBLIC. RESULTS FROM THE CROSS-SECTIONAL SURVEY IN THE HAEMATOLOGY-ONCOLOGICAL CENTERS
Author(s)
Ondrusova M1, Psenkova M1, Suchansky M1, Vranovsky A2, Chudej J3, Wild A4
1Pharm-In Ltd, Bratislava, Slovak Republic, 2National Cancer Institute, Bratislava, Slovak Republic, 3University hospital Martin, Martin, Slovak Republic, 4University Hospital F. D. Roosvelt, Banska Bystrica, Slovak Republic
OBJECTIVES: The objective of this cross-sectional survey was to measure the resource utilisation and costs associated with health-care management of patients with aggressive histological types of Non-hodgkin lymphomas (a-NHLs) in Slovakia and to provide a basis for cost-effectiveness evaluations. The latest official national data on epidemiology of all NHLs are available for year 2008, prediction to 2015 indicates the age-standardized (ASR-W) incidence to be 4.9/100,000 (n=446 cases), from that DLBCL is estimated to be 311 cases (3.1/100,000). Overall point prevalence of all NHLs is estimated to 1,404 patients. METHODS: Descriptive data of 1,080 a-NHLs patients from 3 biggest NHLs-centers from whole Slovakia were collected and analyzed. All types of health-care services, treatment management and costs were analyzed. Continuous variables were calculated using standard descriptive statistics methods. RESULTS:
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PCN119
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Oncology